Ramy Younes
Boehringer Ingelheim (Germany) · 117 works · 6,413 citations · h-index 29
Top works
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
- Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
- The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
- A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
- Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
- Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease
- Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
- Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
- Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
- NASH in Lean Individuals
- Should we undertake surveillance for HCC in patients with NAFLD?
- Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
- An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
- Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
- Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
- Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
- Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease
- Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease